Status:
TERMINATED
Dual Transcranial Direct Current Stimulation (dTDCS)-Enhanced Therapy After Hemorrhagic Strokes and VEGF
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
American Heart Association
Conditions:
Hemorrhagic Stroke
Hemiparesis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study will evaluate the feasibility of dual tDCS to improve arm motor function in chronic stroke patients. In addition it will collect pilot data on the blood biomarkers associated with treatment...
Detailed Description
The proposed, increased intensity dtDCS is a new, economical, noninvasive stimulation approach that has the potential for large-scale clinical application. Dual tDCS, in conjunction with physical and ...
Eligibility Criteria
Inclusion
- Patients (18-85 yo) with arm weakness (uFM \<60) as a result of an ICH and no history of other neurologic or psychiatric illness that are able to activate wrist flexors (\> MRC 1);
- Patients with symptomatic ICH \>5 months before enrollment;
- Ashworth spasticity score \<3.
Exclusion
- Patients with severe uncontrolled medical problems,
- Patients with subarachnoid, subdural or epidural hemorrhage;
- Patients with unstable cardiac arrhythmia;
- Patients with contraindication to tDCS stimulation;
- Patients who are not available for follow-up or unable to follow study procedures;
- Pregnancy
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 17 2017
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03857243
Start Date
January 1 2014
End Date
April 17 2017
Last Update
November 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390